DiaSorin offers the tests for all major Thyroid markers for diagnosis, follow-up and monitoring of treatment of thyroid diseases (autoimmune and cancer included) using CLIA technology and LIAISON® systems.
In vitro assay for the quantitative determination of thyroid-stimulating hormone (TSH) in human serum and plasma. The test has to be performed on the LIAISON® Analyzer family.
In vitro assay for the quantitative determination of free triiodothyronine (FT3) in human serum and plasma. The test has to be performed on the LIAISON® Analyzer family.
In vitro assay for the quantitative determination of free thyroxine (FT4) in human serum and plasma. The test has to be performed on the LIAISON® Analyzer family.
In vitro assay for the quantitative determination of total triiodothyronine (T3) in human serum as well as in heparinised and EDTA plasma. The test has to be performed on the LIAISON® Analyzer.
In vitro assay for the quantitative determination of total thyroxine (T4) in human serum and human plasma. The test has to be performed on the LIAISON® Analyzer.
Fully automated chemiluminescent immunoassay for the quantitative determination of human thyroglobulin (hTg) in human serum as well as in human plasma.
In vitro assay for the quantitative determination of autoantibodies against thyroglobulin (Tg) in human serum as well as in EDTA and heparinised human plasma. The test has to be performed on the LIAISON® Analyzer.
In vitro assay for the quantitative determination of autoantibodies against thyroid peroxidase (TPO) in human serum as well as in EDTA, citrated and heparinised human plasma. The test has to be performed on the LIAISON® Analyzer.
Around 200 million people worlwide have some form of thyroid disease, with 1 billion people worldwide estimated to be at risk for developing a thyroid goiter. Women are 5 to 8 times more likely than men to develop some form of thyroid disease.
Along with the traditional and consolidated first line assays for assessing the thyroid function (fT4, TSH) DiaSorin offers the opportunity to further investigate thyroid diseases with fT3 and with tests for the measurement of autoantibodies to Thyroglobulin (Tg) and Thyroid Peroxidase (TPO). The classical assays for the measurement of total T3 and total T4 are available using either RIA technology or on LIAISON® systems.
Furthermore the Thyroglobulin, even if it is a fully recognized tumor marker, is included in the Thyroid panel. In spite of its physiological role transportation at Thyroid hormones via thyroid cells, from the thyroid hormones to be released in the blood, from the diagnosticaly point of view Tg helps in the characterization of the presence of the undifferentiated tumor of the thyroid and to monitor recurrences after therapy or surgery.
